These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 16361213)

  • 1. Harm reduction ethics: a promising basis for drug policy.
    Miller P
    Drug Alcohol Rev; 2005 Nov; 24(6):553-4. PubMed ID: 16361213
    [No Abstract]   [Full Text] [Related]  

  • 2. Ushering in another harm reduction era? Discursive authenticity, drug policy and research.
    Hathaway AD
    Drug Alcohol Rev; 2005 Nov; 24(6):549-50. PubMed ID: 16361211
    [No Abstract]   [Full Text] [Related]  

  • 3. Moral frameworks, ethical engagement and harm reduction: commentary on 'Ethical challenges and responses in harm reduction research: promoting applied communitarian ethics' by C. L. Fry, C. Treloar & L. Maher.
    Keane H
    Drug Alcohol Rev; 2005 Nov; 24(6):551-2. PubMed ID: 16361212
    [No Abstract]   [Full Text] [Related]  

  • 4. Applied communitarian ethics for harm reduction: promoting a dialogue within the field.
    Fry C; Treloar C; Maher L
    Drug Alcohol Rev; 2007 Sep; 26(5):553-5. PubMed ID: 17701519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethical challenges and responses in harm reduction research: promoting applied communitarian ethics.
    Fry CL; Treloar C; Maher L
    Drug Alcohol Rev; 2005 Sep; 24(5):449-59. PubMed ID: 16298840
    [No Abstract]   [Full Text] [Related]  

  • 6. Using words: the harm reduction conception of drug use and drug users.
    Stafford N
    Int J Drug Policy; 2007 Mar; 18(2):88-91. PubMed ID: 17689350
    [No Abstract]   [Full Text] [Related]  

  • 7. How the harm reduction movement contrasts itself against punitive prohibition.
    Tammi T; Hurme T
    Int J Drug Policy; 2007 Mar; 18(2):84-7. PubMed ID: 17689349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug policy, harm and human rights: a rationalist approach.
    Stevens A
    Int J Drug Policy; 2011 May; 22(3):233-8. PubMed ID: 21481578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strengthening drug policy and practice through ethics engagement: an old challenge for a new harm reduction.
    Irwin KS; Fry CL
    Int J Drug Policy; 2007 Mar; 18(2):75-83. PubMed ID: 17689348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal timing of use reduction vs. harm reduction in a drug epidemic model.
    Caulkins JP; Tragler G; Wallner D
    Int J Drug Policy; 2009 Nov; 20(6):480-7. PubMed ID: 19361975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Harm reduction--an ethical imperative.
    Van Beek I
    Addiction; 2009 Mar; 104(3):342-3; discussion 345-6. PubMed ID: 19207339
    [No Abstract]   [Full Text] [Related]  

  • 12. From harm reduction to human rights: bringing liberalism back into drug reform debates.
    Hathaway AD
    Drug Alcohol Rev; 2002 Dec; 21(4):397-404. PubMed ID: 12537711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. We still need communitarian ethics in harm reduction research.
    Mooney G
    Drug Alcohol Rev; 2006 Jul; 25(4):373-4. PubMed ID: 16854665
    [No Abstract]   [Full Text] [Related]  

  • 14. Ethical challenges and responses in harm reduction research: a critique of applied communitarian ethics.
    Loff B
    Drug Alcohol Rev; 2006 Jul; 25(4):371-2. PubMed ID: 16854664
    [No Abstract]   [Full Text] [Related]  

  • 15. Erasing pleasure from public discourse on illicit drugs: on the creation and reproduction of an absence.
    Moore D
    Int J Drug Policy; 2008 Oct; 19(5):353-8. PubMed ID: 17728122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Putting at risk what we know: reflecting on the drug-using subject in harm reduction and its political implications.
    Moore D; Fraser S
    Soc Sci Med; 2006 Jun; 62(12):3035-47. PubMed ID: 16413645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The issue of harm reduction in Polish legislation concerning drug addiction. A comparative study].
    Sobeyko J
    Ann Acad Med Stetin; 2008; 54(2):119-31. PubMed ID: 19374242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Harm reduction coming of age: A summary of the '18th International Conference on the Reduction of Drug Related Harm'-Warsaw, Poland: 13-17 May 2007.
    Moskalewicz J; Barrett D; Bujalski M; Dabrowska K; Klingemann H; Klingemann J; Malczewski A; Struzik M
    Int J Drug Policy; 2007 Dec; 18(6):503-8. PubMed ID: 18061432
    [No Abstract]   [Full Text] [Related]  

  • 19. A review of the efficacy and effectiveness of harm reduction strategies for alcohol, tobacco and illicit drugs.
    Ritter A; Cameron J
    Drug Alcohol Rev; 2006 Nov; 25(6):611-24. PubMed ID: 17132577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Casting light on harm reduction: introducing two instruments for analysing contradictions between harm reduction and 'non-harm reduction'.
    Jourdan M
    Int J Drug Policy; 2009 Nov; 20(6):514-20. PubMed ID: 19349155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.